ClinicalTrials.gg
CompletedNCT03393559Updated Dec 27, 2019

Effect of Leg Elevation on Prevention of Intraoperative Hypotension During Beach Chair Position

An interventional study of leg elevation in Intraoperative Hypotension, Cerebral Ischemia and Shoulder Disease, sponsored by Seoul National University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 19 Years to 80 Years. Per ClinicalTrials.gov, last updated 2019-12-27.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
19 Years to 80 Years
Sex
All
01

Study summary

The aim of this study is to evaluate the effect of leg elevation on the prevention of intraoperative hypotension during shoulder surgery in the Beach-chair position. patients undergoing shoulder surgery in the Beach-chair position will be randomly assigned to Group L (with leg elevation) or Group C (no intervention). The primary outcome is the incidence of intraoperative hypotension (mean blood pressure \< 60mmHg or systolic blood pressure \< 80% of baseline). Secondary outcomes are the incidence of intraoperative cerebral desaturation (cerebral oxygen saturation \< 80% of baseline, longer than 30 seconds), total amounts of administered inotropic agents, and systolic blood pressure, heart rate, and cerebral oxygen saturation at various time points.

02

Conditions studied

  • Intraoperative Hypotension
  • Cerebral Ischemia
  • Shoulder Disease

Browse trials for

03

In context

Brain Ischemia

217 studies on the registry are indexed under Brain Ischemia; 42 are open to participants now.

This study's enrollment of 50 is below the median of 73 across 140 interventional studies indexed under Brain Ischemia.

Browse Brain Ischemia studies →

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,900 studies on the registry; 274 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adult patients undergoing shoulder surgery in the beach chair position

Exclusion criteria

Exclusion Criteria:

  • Patients with myocardial infarction
  • Patients with pacemaker
  • Patients with cerebrovascular disease
  • patients with arteriovenous fistula at the opposite arm
  • Patients with autonomic nerve disorders
  • Patients with hip or knee joint disorder limiting hip or knee flexion
  • > 30 kg/m2
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Group L

    leg elevation during the beach chair position

    Procedure: leg elevation

  • No intervention
    Group C

    Patients' leg will be straightened without any intervention.

Interventions

  • Procedureleg elevation

    Patients' leg will be raised by a pillow under both legs and the hip and knee joints will be flexed 45 degrees to position both knees at the heart level.

06

What researchers measure

Primary outcomes

  1. Incidence of intraoperative hypotension

    Mean blood pressure \< 60 mmHg or systolic blood pressure \< 80% of baseline

    Time frame: From beach chair positioning to the end of surgery (average of 1 hour up to 2 hours)

Secondary outcomes

  1. Incidence of intraoperative cerebral desaturation

    Cerebral oxygen saturation \< 80% of baseline longer than 30 seconds

    Time frame: From beach chair positioning to the end of surgery (average of 1 hour up to 2 hours)

  2. Total amounts of administered inotropic agents

    Total amounts of administered inotropic agents after the Beach-chair positioning

    Time frame: From beach chair positioning to the end of surgery (average of 1 hour up to 2 hours)

  3. Systolic blood pressure

    Systolic blood pressure in mmHg at multiple time-points

    Time frame: before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning

  4. Heart rate

    Heart rate in bpm at multiple time-points

    Time frame: before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning

  5. Peripheral oxygen saturation

    Peripheral oxygen saturation in percentage at multiple time-points

    Time frame: before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning

  6. Cerebral oxygen saturation

    Cerebral oxygen saturation in percentage at multiple time-points

    Time frame: before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning

07

Study locations

1 site
  • Seoul National University Hospital
    Seoul, 110-744, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: IPD will be made available after article publication, for 3 years from the study completion.

Access criteria: Proposals should be directed to the corresponding author and will be reviewed by the study group. Only requests that have a methodologically sound proposal and whose proposed use of the data has been approved by the independent review committee will be considered.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2018 to primary completion in Dec 2019, 22 months.

Of 43 interventional studies with no phase under Brain Ischemia, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 53. This study's 22 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 26, 2017
First posted
Jan 8, 2018
StartActual
Jan 24, 2018
Primary completionActual
Dec 11, 2019
CompletionActual
Dec 21, 2019
Last update
Dec 27, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 27, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03393559
Responsible party
Jin-Tae Kim (Associate Professor, Seoul National University Hospital) — Principal investigator
First posted
Jan 8, 2018
Start date
Jan 24, 2018
Primary completion
Dec 11, 2019
Completion
Dec 21, 2019
Last update
Dec 27, 2019

Study contacts

Jin-Tae Kim, PhD
principal investigator · Seoul National University Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion